p105·IκBγ and Prototypical IκBs Use a Similar Mechanism to Bind but a Different Mechanism to Regulate the Subcellular Localization of NF-κB*

p105, also known as NF-κB1, is an atypical IκB molecule with a multi-domain organization distinct from other prototypical IκBs, like IκBα and IκBβ. To understand the mechanism by which p105 binds and inhibits NF-κB, we have used both p105 and its C-terminal inhibitory segment known as IκBγ for our study. We show here that one IκBγ molecule binds to NF-κB dimers wherein at least one NF-κB subunit is p50. We suggest that the obligatory p50 subunit in IκBγ·NF-κB complexes is equivalent to the N-terminal p50 segment in all p105·NF-κB complexes. The nuclear localization signal (NLS) of the obligatory p50 subunit is masked by IκBγ, whereas the NLS of the nonobligatory NF-κB subunit is exposed. Thus, the global binding mode of all IκB·NF-κB complexes seems to be similar where one obligatory (or specific) NF-κB subunit makes intimate contact with IκB and the nonobligatory (or nonspecific) subunit is bound primarily through its ability to dimerize. In the case of IκBα and IκBβ, the specific NF-κB subunit in the complex is p65. In contrast to IκBα·NF-κB complexes, where the exposed NLS of the nonspecific subunit imports the complex to the nucleus, p105·NF-κB and IκBγ·NF-κB complexes are cytoplasmic. We show that the death domain of p105 (also of IκBγ) is essential for the cytoplasmic sequestration of NF-κB by p105 and IκBγ. However, the death domain does not mask the exposed NLS of the complex. We also demonstrate that the death domain alone is not sufficient for cytoplasmic retention and instead functions only in conjunction with other parts in the three-dimensional scaffold formed by the association of the ankyrin repeat domain (ARD) and NF-κB dimer. We speculate that additional cytoplasmic protein(s) may sequester the entire p105·NF-κB complex by binding through the death domain and other segments, including the exposed NLS.

[1]  M. Belich,et al.  The Death Domain of NF-κB1 p105 Is Essential for Signal-induced p105 Proteolysis* , 2002, The Journal of Biological Chemistry.

[2]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[3]  G. Ghosh,et al.  IκBβ, but Not IκBα, Functions as a Classical Cytoplasmic Inhibitor of NF-κB Dimers by Masking Both NF-κB Nuclear Localization Sequences in Resting Cells* , 2001, The Journal of Biological Chemistry.

[4]  P. Cramer,et al.  Crystal structure of the ankyrin repeat domain of Bcl‐3: a unique member of the IκB protein family , 2001, The EMBO journal.

[5]  C. Weber,et al.  The death domain superfamily: a tale of two interfaces? , 2001, Trends in biochemical sciences.

[6]  A. Ciechanover,et al.  Processing of p105 Is Inhibited by Docking of p50 Active Subunits to the Ankyrin Repeat Domain, and Inhibition Is Alleviated by Signaling via the Carboxyl-terminal Phosphorylation/ Ubiquitin-Ligase Binding Domain* , 2001, The Journal of Biological Chemistry.

[7]  T. Muta,et al.  A Novel IκB Protein, IκB-ζ, Induced by Proinflammatory Stimuli, Negatively Regulates Nuclear Factor-κB in the Nuclei* , 2001, The Journal of Biological Chemistry.

[8]  W. Tam,et al.  IκB Family Members Function by Different Mechanisms* , 2001, The Journal of Biological Chemistry.

[9]  A. Ciechanover,et al.  Mechanisms of ubiquitin-mediated, limited processingof the NF-κB1 precursor protein p105 , 2001 .

[10]  C. Scheidereit,et al.  Shared Pathways of IκB Kinase-Induced SCFβTrCP-Mediated Ubiquitination and Degradation for the NF-κB Precursor p105 and IκBα , 2001, Molecular and Cellular Biology.

[11]  E. Harhaj,et al.  NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .

[12]  M. Morimatsu,et al.  MAIL, a novel nuclear IκB protein that potentiates LPS‐induced IL‐6 production , 2000 .

[13]  W. Greene,et al.  Cotranslational dimerization of the Rel homology domain of NF‐κB1 generates p50–p105 heterodimers and is required for effective p50 production , 2000, The EMBO journal.

[14]  G. Ghosh,et al.  Mechanism of IκBα Binding to NF-κB Dimers* , 2000, The Journal of Biological Chemistry.

[15]  A. Ciechanover,et al.  SCFβ‐TrCP ubiquitin ligase‐mediated processing of NF‐κB p 105 requires phosphorylation of its C‐terminus by IκB kinase , 2000 .

[16]  W. Tam,et al.  Cytoplasmic Sequestration of Rel Proteins by IκBα Requires CRM1-Dependent Nuclear Export , 2000, Molecular and Cellular Biology.

[17]  Minoru Yoshida,et al.  A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes , 2000 .

[18]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[19]  T. Hope,et al.  An N‐terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα , 1999 .

[20]  F. E. Chen,et al.  Construction, expression, purification and functional analysis of recombinant NFkappaB p50/p65 heterodimer. , 1999, Protein engineering.

[21]  A. Ciechanover,et al.  Structural Motifs Involved in Ubiquitin-Mediated Processing of the NF-κB Precursor p105: Roles of the Glycine-Rich Region and a Downstream Ubiquitination Domain , 1999, Molecular and Cellular Biology.

[22]  G. Ghosh,et al.  The Crystal Structure of the IκBα/NF-κB Complex Reveals Mechanisms of NF-κB Inactivation , 1998, Cell.

[23]  S. Harrison,et al.  Structure of an IκBα/NF-κB Complex , 1998, Cell.

[24]  W. Greene,et al.  Cotranslational Biogenesis of NF-κB p50 by the 26S Proteasome , 1998, Cell.

[25]  G. Ghosh,et al.  Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA , 1998, Nature.

[26]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[27]  T. McKeithan,et al.  Diverse Effects of BCL3 Phosphorylation on Its Modulation of NF-κB p52 Homodimer Binding to DNA* , 1997, The Journal of Biological Chemistry.

[28]  G. Nabel,et al.  A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription , 1997, Molecular and cellular biology.

[29]  A. Israël,et al.  IκB proteins: structure, function and regulation , 1997 .

[30]  A. Israël,et al.  I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .

[31]  G. Nabel,et al.  Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences , 1996, Molecular and cellular biology.

[32]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[33]  S. Ghosh,et al.  A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit , 1996, Molecular and cellular biology.

[34]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[35]  E M Schwarz,et al.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.

[36]  H. Erdjument-Bromage,et al.  IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.

[37]  R. Hay,et al.  Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhinition of NF-ϰB binding activity , 1993 .

[38]  M. Karin,et al.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. , 1993, Genes & development.

[39]  C. Scheidereit,et al.  The NF‐kappa B precursor p105 and the proto‐oncogene product Bcl‐3 are I kappa B molecules and control nuclear translocation of NF‐kappa B. , 1993, The EMBO journal.

[40]  A. Israël,et al.  The precursor of NF-κB p50 has IκB-like functions , 1992, Cell.

[41]  M. Karin,et al.  Molecular Cloning and Characterization of a Novel Rel/NF-χB Family Member Displaying Structural and Functional Homology to NF-χB p50/p105 , 1992 .

[42]  C. Scheidereit,et al.  Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB , 1992, Nature.

[43]  D. Baltimore,et al.  The NF‐kappa B p50 precursor, p105, contains an internal I kappa B‐like inhibitor that preferentially inhibits p50. , 1992, The EMBO journal.

[44]  J. McPherson,et al.  Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. , 1992, Genomics.

[45]  I. Verma,et al.  IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family , 1992, Cell.

[46]  Thomas Henkel,et al.  Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit , 1992, Cell.

[47]  C. Scheidereit,et al.  The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[48]  V. Bours,et al.  A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site , 1992, Molecular and cellular biology.

[49]  S. Haskill,et al.  Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity , 1991, Cell.

[50]  G. Nolan,et al.  Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal , 1990, Cell.

[51]  A. Israël,et al.  The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product , 1990, Cell.

[52]  D. Baltimore,et al.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.